1.8K views · 15 reactions | One year ago, the LifeArc Centre for Rare...

7.2K views · 114 reactions | Judy suffers from mitochondrial disease...

🌟Expanded access can offer hope when no approved treatment exists. When Arturito Estopinan was diagnosed with TK2d, an ultra-rare mitochondrial disease, his family worked with experts to access an investigational therapy. Today, Arturito is thriving, and the FDA has approved the first treatment for TK2d. A powerful step forward for the rare disease community.🙌 👉 Read more about Arturito’s journey and the power of expanded access: https://mdaquest.org/how-expanded-access-and-compassionate-use-